Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Skin Neoplasms 2Keratosis, Actinic 2Cholangiocarcinoma 2Warts 1Skin Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms by Site 1Neoplasms 1Keloid 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Digestive System Diseases 1Constriction, Pathologic 1Cicatrix, Hypertrophic 1Carcinoma 1Biliary Tract Diseases 1Bile Duct Neoplasms 1Bile Duct Diseases 1Adenocarcinoma 1

Interventions

Docetaxel 5Pemetrexed 4Capecitabine 4pembrolizumab 3Oxaliplatin 3icotinib 2Radiation 2Paclitaxel 2Gemcitabine 2Gefitinib 2Fluorouracil 2Drug Therapy 2Chemoradiotherapy 2Carboplatin 2sintilimab 1rucaparib 1regorafenib 1olaparib 1lenvatinib 1iron isomaltoside 1000 1ipatasertib 1iopromide 1gluconic acid 1elemene 1capecitabine-irinotecan combination 1aumolertinib 1atezolizumab 1anlotinib 1aflutinib 1XELOX 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Adenocarcinoma × Photochemotherapy × Clear all
NCT01739465 2013-02-26

Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma

Guangzhou Medical University

Phase 2/3 Unknown
120 enrolled
Gastrointestinal

Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, Carcinoma, Constriction, Pathologic, Digestive System Diseases, Neoplasms, Neoplasms by Site, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡